Protesters took to the streets of lower Manhattan to denounce and protest U.S. Immigration and Customs Enforcement (ICE) on ...

Two new MetroRapid lines in East and Southeast Austin will officially start taking passengers this weekend, says CapMetro.

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company Vertex Pharmaceuticals on Thursday. The drug, which is called suzetrigine ...

The Summerlin master-planned community offers more than 75 unique floor plans in 15 neighborhoods throughout eight distinct ...

At the recent 210mm Five-Year Ecological Innovation Conference, Dr. Zhang Yingbin, Head of Strategy, Product, and Marketing at Trinasolar, took the stage to highlight the transformative impact of the ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.

Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Empowered Funds LLC purchased a new stake in Vertex, Inc. (NASDAQ:VERX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.

Vertex Pharmaceuticals (NASDAQ: VRTX) has many promising treatments in its pipeline, as it looks to build out its business beyond just the cystic fibrosis (CF) drugs that have enabled it to post ...